Suchergebnisse - "Tang, Hailin"

PubPharm (10)

1

N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer

enthalten in: Nature communications | 2022

von Zou, Y. | Zheng, S. | Xie, X. | +14

2

Synergistic therapeutic effect of combined PDGFR and SGK1 inhibition in metastasis-initiating cells of breast cancer

enthalten in: Cell death and differentiation | 2020

von Yang, L. | Li, N. | Xue, Z. | +7

3

Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes : A SEER Population-Based Study

enthalten in: Cancer control : journal of the Moffitt Cancer Center | 2020

von Yu, P. | Tang, H. | Zou, Y. | +5

4

miR-200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer

enthalten in: Journal of cellular and molecular medicine | 2019

von Tang, H. | Song, C. | Ye, F. | +5

5

Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer

enthalten in: Current cancer drug targets | 2019

von Liu, P. | Tang, H. | Wu, J. | +5

6

Application of a novel prognostic invasive lesion index in ductal carcinoma in situ with minimal invasion of the breast

enthalten in: Cancer medicine | 2017

von He, X. | Ye, F. | Li, M. | +4

7

Caveolin-1-mediated Japanese encephalitis virus entry requires a two-step regulation of actin reorganization

enthalten in: Future microbiology | 2016

von Xu, Q. | Cao, M. | Song, H. | +9

8

Abnormal phosphorylation of Tie2/Akt/eNOS signaling pathway and decreased number or function of circulating endothelial progenitor cells in prehypertensive premenopausal women with diabetes mellitus

enthalten in: BMC endocrine disorders | 2016

von Zeng, H. | Jiang, Y. | Tang, H. | +3

9

Nrdp1 expression to predict clinical outcome and efficacy of adjuvant anthracyclines-based chemotherapy in breast cancer : A retrospective study

enthalten in: Cancer biomarkers : section A of Disease markers | 2015

von Jiao, S. | Liu, W. | Wu, M. | +3

10

Co-expression of EGFR and CK5/6 in primary squamous cell carcinoma of the breast

enthalten in: Medical oncology (Northwood, London, England) | 2014

von Wang, J. | Zhang, X. | He, J. | +5

1
[1]